TAK-715 and methotrexate ( DrugBank: Methotrexate, TAK-715 )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00760864 (ClinicalTrials.gov) | August 2004 | 24/9/2008 | Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis | A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis | Arthritis, Rheumatoid | Drug: TAK-715 and methotrexate;Drug: Methotrexate | Takeda | NULL | Completed | 18 Years | N/A | Both | 432 | Phase 2 | NULL |